Prostatic malignancy.
D000135:Acid Phosphatase / Q000097:blood; D000230:Adenocarcinoma / Q000556:secondary / Q000628:therapy; D000726:Androgen Antagonists / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000556:secondary; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000628:therapy
D000726:Androgen Antagonists; D000135:Acid Phosphatase